Bruker Daltonics Introduces Next-Generation Horizontal Top-of-the-Line MALDI-TOF/TOF Mass Spectrometer at IMSC

PRAGUE, Czech Republic--(BUSINESS WIRE)--Aug. 27, 2006--

Next-Generation ultraflex III Offers Unique Smartbeam Technology, Further Boosts Sensitivity and Triples Acquisition Speed for Most Advanced LC-MALDI Workflow

At the 17th International Mass Spectrometry Conference IMSC, Bruker Daltonics today announces its next-generation horizontal top-of-the-line ultraflex(R) III smartbeam(TM) MALDI-TOF/TOF mass spectrometer. The new ultraflex III combines (...)

Bruker Daltonics Introduces High Performance Compact Vertical MALDI-TOF/TOF Mass Spectrometer at IMSC

PRAGUE, Czech Republic--(BUSINESS WIRE)--Aug. 27, 2006--

New Autoflex III Offers Unique Smartbeam Technology, a 4-fold Sensitivity Increase and Enhanced PAN Mass Resolution Over Broad Mass Range of Peptides

At the 17th International Mass Spectrometry Conference, Bruker Daltonics today announces its new autoflex(R) III smartbeam(TM) vertical MALDI-TOF or TOF/TOF mass spectrometer. Mass resolution and accuracy, sensitivity, analytical versatility and (...)

Bruker Daltonics to Present at the International Mass Spectrometry Conference (IMSC) in Prague on Clinical Proteomics, MALDI Imaging, Ion Trap ETD, FTMS and Metabolomics

PRAGUE, Czech Republic--(BUSINESS WIRE)--Aug. 26, 2006--

At the 2006 International Mass Spectrometry Conference, Bruker Daltonics will make numerous presentations on mass spectrometry applications in proteomics and clinical research solutions, as well as in small molecule analysis and metabolomics. On Tuesday, August 29, 2006, top Bruker Daltonics scientists will lead in-depth discussions of the following topics at a luncheon seminar from 1:15 to 2:15 (...)

Bruker BioSciences Reports Solid Revenue Growth and Improved Earnings in Second Quarter 2006

BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 1, 2006--Bruker BioSciences Corporation (NASDAQ: BRKR) today reported second quarter 2006 results. On July 1, 2006, Bruker BioSciences completed its acquisition of Bruker Optics Inc. Due to the Laukien family majority ownership of both companies, this acquisition is required to be accounted for as a pooling of interests. As a result of this accounting treatment, all historical periods will be restated beginning in (...)

Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement with Bruker Daltonics

SAVANNAH, Ga.--(BUSINESS WIRE)--Aug. 1, 2006--

New Capability Assists Researchers and Pharmaceutical Firms in Biomarker Discovery and Validation, Discovering Drug Targets, and Personalized Medicine

Health Discovery Corporation ("HDC") today announced that it has executed a non-exclusive worldwide license agreement with Bruker Daltonics Inc. covering Bruker Daltonics' use of HDC's Support Vector Machine ("SVM") technology in the ClinProTools(TM) (...)

Bruker Daltonics and Isis Pharmaceuticals Enter Into Manufacturing and Distribution Agreement for Ibis T5000 Biosensor System

BILLERICA, Mass. and CARLSBAD, Calif., July 31 /PRNewswire-FirstCall/ --

Bruker Daltonics, a subsidiary of Bruker BioSciences (Nasdaq: BRKR), and Isis Pharmaceuticals (Nasdaq: ISIS) announce today a strategic alliance for manufacturing and distribution of Isis' Ibis T5000(TM) biosensor system. The Ibis T5000, developed by Isis' Ibis Biosciences(TM) division, is a universal biosensor system that can simultaneously identify thousands of types of (...)

Bruker BioSciences Corporation to Release Second Quarter 2006 Financial Results on August 1, 2006

BILLERICA, Mass.--(BUSINESS WIRE)--July 26, 2006--

Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its second quarter financial results on Tuesday, August 1, 2006 after the market closes. Bruker BioSciences will then host an operator-assisted earnings conference call the following morning, Wednesday, August 2, at 9 a.m. Eastern Time, 6 a.m. Pacific Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on (...)

Bruker BioSciences Announces Closing of Acquisition of Bruker Optics

BILLERICA, Mass.--(BUSINESS WIRE)--July 5, 2006--

Bruker BioSciences Corporation (NASDAQ: BRKR) announces today that on July 1st, 2006 it closed the acquisition of molecular spectroscopy company Bruker Optics Inc. for $135 million, payable approximately 59% in cash and 41% in BRKR stock. Approximately 11.4 million new Bruker BioSciences shares were issued for the stock component of the purchase consideration. The number of Bruker BioSciences shares (...)

Bruker BioSciences Shareholders Approve Acquisition of Bruker Optics; Combined Company to Be a Leading Provider of Molecular Analysis Solutions to the Life Science, Materials Research, Homeland Security and Industrial Markets

BILLERICA, Mass.--(BUSINESS WIRE)--June 29, 2006--

Bruker BioSciences Corporation (NASDAQ: BRKR) announces after the Company's Annual Meeting today that its shareholders have approved the acquisition of molecular spectroscopy company Bruker Optics Inc. for $135 million, to be paid approximately 59% in cash and 41% in BRKR stock. The acquisition agreement had previously received unanimous approval by a Special Committee of independent directors of the (...)

Bruker Daltonics Launches RAID-AFM and RAID-S2 for Long-Term Chemical Monitoring in Homeland Security and Defense Infrastructure Protection

TAMPERE, Finland--(BUSINESS WIRE)--June 20, 2006--

The NBC Detection Business of Bruker Daltonik GmbH, based in Leipzig, Germany, today announces the RAID(TM)-AFM and the RAID(TM)-S2, two new stationary chemical detectors, at the NBC 2006 Symposium on Chemical, Biological, Nuclear and Radiological Threats in Tampere, Finland.

For over 15 years, Bruker Daltonics has been recognized as a leading expert in chemical detection applications of ion mobility (...)